LANGLEY HOUSE SURGERY — All Prescriptions & Medications — Page 8
Practice Code: H82013 | CHICHESTER, PO19 1RW
Showing results 351-400 of 727
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Pizotifen malate | 92 | 6,196 | £277 | +11.6% ▲ |
| Benzoyl peroxide and clindamycin phosphate | 92 | 2,910 | £1.2K | +37.2% ▲ |
| Dabigatran etexilate | 91 | 5,420 | £4.3K | +75.8% ▲ |
| Biphasic insulin aspart | 91 | 690 | £4.0K | -10.4% ▼ |
| Vortioxetine | 90 | 2,828 | £2.6K | +29.7% ▲ |
| Midazolam hydrochloride | 90 | 708 | £389 | +119.9% ▲ |
| 90 | 2,655 | £2.7K | +422.6% ▲ | |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 89 | 799.0K | £10.0K | +103.4% ▲ |
| Hydralazine hydrochloride | 87 | 2,807 | £163 | +106.2% ▲ |
| Ketone blood testing reagents | 87 | 1,100 | £1.1K | +28.6% ▲ |
| Metronidazole | 86 | 1,935 | £223 | +30.9% ▲ |
| Testosterone | 86 | 5,172 | £2.8K | +12.7% ▲ |
| 84 | 417 | £1.7K | +22.6% ▲ | |
| Rivastigmine | 83 | 2,680 | £4.0K | +20.6% ▲ |
| Anastrozole | 83 | 2,352 | £91 | -8.8% ▼ |
| Duloxetine hydrochloride | 82 | 2,296 | £470 | +60.0% ▲ |
| Leflunomide | 82 | 2,610 | £872 | +116.7% ▲ |
| Hepatitis A | 82 | 82 | £1.5K | +8.0% ▲ |
| Other toiletry preparations | 81 | 41.8K | £627 | +89.6% ▲ |
| 81 | 3,426 | £318 | +62.3% ▲ | |
| 81 | 21.2K | £2.4K | +106.1% ▲ | |
| 80 | 12.6K | £1.2K | +65.9% ▲ | |
| Nizatidine | 79 | 3,274 | £2.9K | +129.6% ▲ |
| Pioglitazone hydrochloride | 79 | 2,212 | £127 | -10.7% ▼ |
| Domperidone | 78 | 5,330 | £116 | +118.7% ▲ |
| Metronidazole | 77 | 3,185 | £881 | +104.9% ▲ |
| Dutasteride | 76 | 2,252 | £134 | +48.0% ▲ |
| Levonorgestrel | 76 | 77 | £5.6K | +101.4% ▲ |
| Metoprolol tartrate | 75 | 2,142 | £221 | +47.9% ▲ |
| 75 | 9,210 | £15.6K | +254.3% ▲ | |
| Carvedilol | 74 | 2,450 | £97 | -34.8% ▼ |
| 74 | 4,520 | £390 | +6.0% ▲ | |
| Amiloride hydrochloride | 73 | 3,066 | £1.5K | +190.0% ▲ |
| Insulin Lispro | 72 | 400 | £2.9K | -5.9% ▼ |
| Bempedoic acid | 71 | 1,988 | £3.6K | +116.6% ▲ |
| Ascorbic acid | 70 | 595 | £888 | +240.9% ▲ |
| Heparinoid | 70 | 3,550 | £265 | +436.8% ▲ |
| Amiodarone hydrochloride | 69 | 1,932 | £109 | +7.0% ▲ |
| Dexamfetamine sulfate | 69 | 9,028 | £8.3K | +91.9% ▲ |
| Risedronate sodium | 69 | 304 | £78 | -43.1% ▼ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 68 | 1,505 | £199 | +95.5% ▲ |
| Lacidipine | 68 | 2,044 | £171 | -43.1% ▼ |
| Medroxyprogesterone acetate | 68 | 70 | £418 | -43.7% ▼ |
| Sennosides | 67 | 27.3K | £507 | +116.9% ▲ |
| 67 | 2,263 | £6.9K | +68.0% ▲ | |
| Ursodeoxycholic acid | 66 | 4,972 | £720 | -0.3% vs avg |
| Zolmitriptan | 66 | 762 | £3.3K | +1.6% vs avg |
| Rasagiline mesilate | 66 | 2,044 | £1.2K | +77.7% ▲ |
| 66 | 1,100 | £3.5K | +114.8% ▲ | |
| 66 | 534 | £1.0K | +351.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.